GlassScriptPhysician profile
Catherine Cooper
NPI 1730539214
$2,775.50
in general payments reported to CMS, 2019-2025
10 companies · $1,262 in 2025
The $1,262 reported for 2025 was more than what 90% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.92 · 2022: $14.17 · 2023: $1,245 · 2024: $192 · 2025: $1,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,766 · Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,765.97 |
| Food and Beverage | $933.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,037.80 | 2023-2025 | Intellis Adaptivestim, Synchromedii, Kyphon Express II Kyphopak Tray |
| Abbvie INC. | $447.37 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $100.43 | 2024-2025 | Dysport |
| Merz Pharmaceuticals, LLC | $75.29 | 2024-2025 | Xeomin |
| Abbott Laboratories | $25.61 | 2021 | |
| Sumitomo Pharma America, INC. | $21.04 | 2023 | Orgovyx |
| Pacira Therapeutics, INC. | $19.20 | 2021 | |
| Piramal Critical Care | $17.48 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $17.11 | 2021 | |
| Allergan, INC. | $14.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.